Ventricular Septal Defect (VSD) is a congenital anomaly affecting the heart, distinguished by an abnormal opening in the ventricular septum—the wall that separates the heart's lower chambers. This condition results in a direct pathway for blood to traverse from the left ventricle to the right ventricle, disrupting the typical flow of oxygenated and deoxygenated blood. Classified among the prevalent congenital heart defects, VSDs exhibit variability in size and severity. Smaller defects might exhibit a tendency to close spontaneously, while larger ones may necessitate medical intervention. The manifestations of VSD can span from mild to severe, encompassing symptoms such as feeding difficulties, inadequate weight gain, and respiratory challenges. Early detection of VSD is critical, as timely management, comprising either pharmaceutical interventions or surgical procedures, is pivotal for addressing the condition and fostering optimal cardiac function. Sustaining proper cardiac health throughout life requires regular monitoring and follow-up care for individuals diagnosed with VSD.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation